Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities
The genus Lactobacillus is a taxonomically complex and is composed of over 170 species that cannot be easily differentiated phenotypically and often require molecular identification. Although they are part of the normal human gastrointestinal and vaginal flora, they can also be occasional human path...
Gespeichert in:
Veröffentlicht in: | Clinical infectious diseases 2015-05, Vol.60 (suppl_2), p.S98-S107 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S107 |
---|---|
container_issue | suppl_2 |
container_start_page | S98 |
container_title | Clinical infectious diseases |
container_volume | 60 |
creator | Goldstein, Ellie J. C. Tyrrell, Kerin L. Citron, Diane M. |
description | The genus Lactobacillus is a taxonomically complex and is composed of over 170 species that cannot be easily differentiated phenotypically and often require molecular identification. Although they are part of the normal human gastrointestinal and vaginal flora, they can also be occasional human pathogens. They are extensively used in a variety of commercial products including probiotics. Their antimicrobial susceptibilities are poorly defined in part because of their taxonomic complexity and are compounded by the different methods recommended by Clinical Laboratory Standards Institute and International Dairy Foundation. Their use as probiotics for prevention of Clostridium difficile infection is prevalent among consumers worldwide but raises the question of will the use of any concurrent antibiotic effect their ability to survive. Lactobacillus species are generally acid resistant and are able to survive ingestion. They are generally resistant to metronidazole, aminoglycosides and ciprofloxacin with L. acidophilus being susceptible to penicillin and vancomycin, whereas L. rhamnosus and L. casei are resistant to metronidazole and vancomycin. |
doi_str_mv | 10.1093/cid/civ072 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1677894811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26367192</jstor_id><sourcerecordid>26367192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-d87e16de473fbb45534601d4a3394fa189ab693b2642d2d09209c9fbc4069ad3</originalsourceid><addsrcrecordid>eNpd0M9LwzAUB_AgipvTi3el4EWEan41TbzJ8BcMPWz3kiYpZLRNTdqx_fdmdCp4CMnjffJ4fAG4RPAeQUEelNXxbGCOj8AUZSRPWSbQcXzDjKeUEz4BZyGsIUSIw-wUTHAmMKaQT8HHQqrelVLZuh5CsuyMsiY8Jiu5da1rrErmrulqs7X9LpGtjmXbe7cxPlhZJ8shKNP1trS17ePHc3BSyTqYi8M9A6uX59X8LV18vr7PnxapIjnpU81zg5g2NCdVWdIsI5RBpKkkRNBKIi5kyQQpMaNYYw0FhkKJqlQUMiE1mYHbcWzn3ddgQl80Ni5S17I1bggFYnnOBeUIRXrzj67d4Nu43F6JqCDDUd2NSnkXgjdV0XnbSL8rECz2IRcx5GIMOeLrw8ihbIz-pT-pRnA1gnXonf_rM8JyJDD5Bs56gf8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1679894062</pqid></control><display><type>article</type><title>Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Goldstein, Ellie J. C. ; Tyrrell, Kerin L. ; Citron, Diane M.</creator><creatorcontrib>Goldstein, Ellie J. C. ; Tyrrell, Kerin L. ; Citron, Diane M.</creatorcontrib><description>The genus Lactobacillus is a taxonomically complex and is composed of over 170 species that cannot be easily differentiated phenotypically and often require molecular identification. Although they are part of the normal human gastrointestinal and vaginal flora, they can also be occasional human pathogens. They are extensively used in a variety of commercial products including probiotics. Their antimicrobial susceptibilities are poorly defined in part because of their taxonomic complexity and are compounded by the different methods recommended by Clinical Laboratory Standards Institute and International Dairy Foundation. Their use as probiotics for prevention of Clostridium difficile infection is prevalent among consumers worldwide but raises the question of will the use of any concurrent antibiotic effect their ability to survive. Lactobacillus species are generally acid resistant and are able to survive ingestion. They are generally resistant to metronidazole, aminoglycosides and ciprofloxacin with L. acidophilus being susceptible to penicillin and vancomycin, whereas L. rhamnosus and L. casei are resistant to metronidazole and vancomycin.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/civ072</identifier><identifier>PMID: 25922408</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibiotics ; Bacteremia - drug therapy ; Bacteremia - microbiology ; Colony Count, Microbial ; Drug resistance ; Drug Resistance, Bacterial ; Female ; Food Microbiology ; Genotype & phenotype ; Gram-Positive Bacterial Infections - drug therapy ; Gram-Positive Bacterial Infections - microbiology ; Humans ; Lactobacillus - classification ; Lactobacillus - drug effects ; Lactobacillus - physiology ; Lactobacillus acidophilus - drug effects ; Lactobacillus acidophilus - physiology ; Lactobacillus casei - drug effects ; Lactobacillus casei - physiology ; Lactobacillus rhamnosus - drug effects ; Lactobacillus rhamnosus - metabolism ; Metronidazole - pharmacology ; Microbial Sensitivity Tests ; Probiotics</subject><ispartof>Clinical infectious diseases, 2015-05, Vol.60 (suppl_2), p.S98-S107</ispartof><rights>The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</rights><rights>Copyright Oxford University Press, UK May 15, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-d87e16de473fbb45534601d4a3394fa189ab693b2642d2d09209c9fbc4069ad3</citedby><cites>FETCH-LOGICAL-c373t-d87e16de473fbb45534601d4a3394fa189ab693b2642d2d09209c9fbc4069ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/26367192$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/26367192$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25922408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Goldstein, Ellie J. C.</creatorcontrib><creatorcontrib>Tyrrell, Kerin L.</creatorcontrib><creatorcontrib>Citron, Diane M.</creatorcontrib><title>Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>The genus Lactobacillus is a taxonomically complex and is composed of over 170 species that cannot be easily differentiated phenotypically and often require molecular identification. Although they are part of the normal human gastrointestinal and vaginal flora, they can also be occasional human pathogens. They are extensively used in a variety of commercial products including probiotics. Their antimicrobial susceptibilities are poorly defined in part because of their taxonomic complexity and are compounded by the different methods recommended by Clinical Laboratory Standards Institute and International Dairy Foundation. Their use as probiotics for prevention of Clostridium difficile infection is prevalent among consumers worldwide but raises the question of will the use of any concurrent antibiotic effect their ability to survive. Lactobacillus species are generally acid resistant and are able to survive ingestion. They are generally resistant to metronidazole, aminoglycosides and ciprofloxacin with L. acidophilus being susceptible to penicillin and vancomycin, whereas L. rhamnosus and L. casei are resistant to metronidazole and vancomycin.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - microbiology</subject><subject>Colony Count, Microbial</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Female</subject><subject>Food Microbiology</subject><subject>Genotype & phenotype</subject><subject>Gram-Positive Bacterial Infections - drug therapy</subject><subject>Gram-Positive Bacterial Infections - microbiology</subject><subject>Humans</subject><subject>Lactobacillus - classification</subject><subject>Lactobacillus - drug effects</subject><subject>Lactobacillus - physiology</subject><subject>Lactobacillus acidophilus - drug effects</subject><subject>Lactobacillus acidophilus - physiology</subject><subject>Lactobacillus casei - drug effects</subject><subject>Lactobacillus casei - physiology</subject><subject>Lactobacillus rhamnosus - drug effects</subject><subject>Lactobacillus rhamnosus - metabolism</subject><subject>Metronidazole - pharmacology</subject><subject>Microbial Sensitivity Tests</subject><subject>Probiotics</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0M9LwzAUB_AgipvTi3el4EWEan41TbzJ8BcMPWz3kiYpZLRNTdqx_fdmdCp4CMnjffJ4fAG4RPAeQUEelNXxbGCOj8AUZSRPWSbQcXzDjKeUEz4BZyGsIUSIw-wUTHAmMKaQT8HHQqrelVLZuh5CsuyMsiY8Jiu5da1rrErmrulqs7X9LpGtjmXbe7cxPlhZJ8shKNP1trS17ePHc3BSyTqYi8M9A6uX59X8LV18vr7PnxapIjnpU81zg5g2NCdVWdIsI5RBpKkkRNBKIi5kyQQpMaNYYw0FhkKJqlQUMiE1mYHbcWzn3ddgQl80Ni5S17I1bggFYnnOBeUIRXrzj67d4Nu43F6JqCDDUd2NSnkXgjdV0XnbSL8rECz2IRcx5GIMOeLrw8ihbIz-pT-pRnA1gnXonf_rM8JyJDD5Bs56gf8</recordid><startdate>20150515</startdate><enddate>20150515</enddate><creator>Goldstein, Ellie J. C.</creator><creator>Tyrrell, Kerin L.</creator><creator>Citron, Diane M.</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20150515</creationdate><title>Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities</title><author>Goldstein, Ellie J. C. ; Tyrrell, Kerin L. ; Citron, Diane M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-d87e16de473fbb45534601d4a3394fa189ab693b2642d2d09209c9fbc4069ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - microbiology</topic><topic>Colony Count, Microbial</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Female</topic><topic>Food Microbiology</topic><topic>Genotype & phenotype</topic><topic>Gram-Positive Bacterial Infections - drug therapy</topic><topic>Gram-Positive Bacterial Infections - microbiology</topic><topic>Humans</topic><topic>Lactobacillus - classification</topic><topic>Lactobacillus - drug effects</topic><topic>Lactobacillus - physiology</topic><topic>Lactobacillus acidophilus - drug effects</topic><topic>Lactobacillus acidophilus - physiology</topic><topic>Lactobacillus casei - drug effects</topic><topic>Lactobacillus casei - physiology</topic><topic>Lactobacillus rhamnosus - drug effects</topic><topic>Lactobacillus rhamnosus - metabolism</topic><topic>Metronidazole - pharmacology</topic><topic>Microbial Sensitivity Tests</topic><topic>Probiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Goldstein, Ellie J. C.</creatorcontrib><creatorcontrib>Tyrrell, Kerin L.</creatorcontrib><creatorcontrib>Citron, Diane M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Goldstein, Ellie J. C.</au><au>Tyrrell, Kerin L.</au><au>Citron, Diane M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2015-05-15</date><risdate>2015</risdate><volume>60</volume><issue>suppl_2</issue><spage>S98</spage><epage>S107</epage><pages>S98-S107</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>The genus Lactobacillus is a taxonomically complex and is composed of over 170 species that cannot be easily differentiated phenotypically and often require molecular identification. Although they are part of the normal human gastrointestinal and vaginal flora, they can also be occasional human pathogens. They are extensively used in a variety of commercial products including probiotics. Their antimicrobial susceptibilities are poorly defined in part because of their taxonomic complexity and are compounded by the different methods recommended by Clinical Laboratory Standards Institute and International Dairy Foundation. Their use as probiotics for prevention of Clostridium difficile infection is prevalent among consumers worldwide but raises the question of will the use of any concurrent antibiotic effect their ability to survive. Lactobacillus species are generally acid resistant and are able to survive ingestion. They are generally resistant to metronidazole, aminoglycosides and ciprofloxacin with L. acidophilus being susceptible to penicillin and vancomycin, whereas L. rhamnosus and L. casei are resistant to metronidazole and vancomycin.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>25922408</pmid><doi>10.1093/cid/civ072</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-4838 |
ispartof | Clinical infectious diseases, 2015-05, Vol.60 (suppl_2), p.S98-S107 |
issn | 1058-4838 1537-6591 |
language | eng |
recordid | cdi_proquest_miscellaneous_1677894811 |
source | Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Anti-Bacterial Agents - pharmacology Antibiotics Bacteremia - drug therapy Bacteremia - microbiology Colony Count, Microbial Drug resistance Drug Resistance, Bacterial Female Food Microbiology Genotype & phenotype Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology Humans Lactobacillus - classification Lactobacillus - drug effects Lactobacillus - physiology Lactobacillus acidophilus - drug effects Lactobacillus acidophilus - physiology Lactobacillus casei - drug effects Lactobacillus casei - physiology Lactobacillus rhamnosus - drug effects Lactobacillus rhamnosus - metabolism Metronidazole - pharmacology Microbial Sensitivity Tests Probiotics |
title | Lactobacillus Species: Taxonomic Complexity and Controversial Susceptibilities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A28%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lactobacillus%20Species:%20Taxonomic%20Complexity%20and%20Controversial%20Susceptibilities&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Goldstein,%20Ellie%20J.%20C.&rft.date=2015-05-15&rft.volume=60&rft.issue=suppl_2&rft.spage=S98&rft.epage=S107&rft.pages=S98-S107&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/civ072&rft_dat=%3Cjstor_proqu%3E26367192%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1679894062&rft_id=info:pmid/25922408&rft_jstor_id=26367192&rfr_iscdi=true |